Depletion studies in murine lymphoma models indicate that DCs—not B cells or macrophages—are indeed the major antigen presenting cell (APC) required for durable anti-tumour immunity, demonstrated when RT is combined with stimulatory CD40 mAb [29]. Here, CD40 is linked to neoplasm.